Volume 34, Issue 4 e15020
ORIGINAL ARTICLE

Comparison of novel aluminium lactate versus aluminium chloride-based antiperspirant in excessive axillary perspiration: First prospective cohort study

Syrus Karsai

Corresponding Author

Syrus Karsai

Dermatologikum Hamburg GmbH, Hamburg, Germany

Department of Dermatology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany

Correspondence

Syrus Karsai, Dermatologikum Hamburg GmbH, Stephansplatz 5, D-20354 Hamburg, Germany.

Email: [email protected]

Search for more papers by this author
Christel Weiß

Christel Weiß

Department of Medical Statistics and Biomathematics, University Medical Centre, Mannheim, Germany

Search for more papers by this author
Constantin Lütgerath

Constantin Lütgerath

Dermatologikum Hamburg GmbH, Hamburg, Germany

Search for more papers by this author
Isabel Ott

Isabel Ott

Department of Dermatology, Klinikum Ludwigshafen, Ludwigshafen am Rhein, Germany

Search for more papers by this author
Jörg Faulhaber

Jörg Faulhaber

MVZ Hautzentrum am Kalten Markt GmbH, Schwäbisch Gmünd, Germany

Search for more papers by this author
First published: 03 June 2021
Citations: 5

Funding information: Sweat-off Inc.

Abstract

Aluminium chloride-based antiperspirants are an effective topical therapeutic option for mild to moderate states of excessive perspiration. Its use is primarily limited by the occurrence of skin irritation, especially in sensitive skin types. The objective of this study was to compare the antiperspirant efficacy and tolerability of a novel antiperspirant with 12.5% aluminium lactate, and a 12.5% aluminium chloride-based antiperspirant. This cohort study was conducted as a two-sided self-assessment comparison between both preparations in healthy volunteers to generate selfcare-related data. Almost half of the participants stated that aluminium chloride was more efficacious than aluminium lactate; 22% stated aluminium lactate was more efficacious than aluminium chloride; 28% observed no difference in the efficacy of both preparations (p = 0.04). However, 88% described greater tolerability with aluminium lactate (p < 0.0001). In this study, aluminium lactate showed significantly greater tolerability than aluminium chloride, although the latter tended to show slightly greater efficacy.

CONFLICT OF INTEREST

Isabel Ott is a former employee of Laserklinik Karlsruhe; the medical director (Prof. Dr. Christian Raulin) is shareholder of Sweat off Inc. The other authors declare no conflict of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request; they are not publicly available due to privacy restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.